Sign in
FBIO Stock Price, Chart, Stats & News
Fortress Biotech, Inc.
Save
Fortress Biotech, Inc. (FBIO) does not currently pay a dividend.
117.26M
Market cap
1.56x
Current P/E
1.39x
Forward P/E
FBIO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 65.83% |
Operating margin | -149.18% |
Pretax margin | -85.82% |
Net margin | 6.40% |
Effective tax rate | -0.68% |
ROA | 2.20% |
ROE | 11.02% |
D/E | 1.22x |
Interest coverage ratio | -9.00x |
FBIO valuation
P/E | 1.56x |
P/S | 1.37x |
P/B | 1.35x |
P/CF | -1.14x |
P/FCF | -1.30x |
P/OCF | -1.14x |
PEG | 0.24x |
EV multiple | -2.67x |
About
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases).
Similar securities
Based on sector and market capitalization
Report issue